Stephanie Okey insider trades

Open-market stock purchases and sales by Stephanie Okey, Director at Crinetics Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 8, 2018.

Recent trades

DateStockTradeValue
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$544K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$504K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$1.5M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$772K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$1.1M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$1.1M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$504K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$545K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$478K
Jun 18, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Jun 18, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Jun 17, 2026CRNX Crinetics Pharmaceuticals, IncSold$224K
Jun 17, 2026CRNX Crinetics Pharmaceuticals, IncSold$22K
Mar 10, 2026PTCT PTC Therapeutics, IncSold$81.7K
Mar 10, 2026PTCT PTC Therapeutics, IncSold$980K
Mar 10, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Mar 10, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Mar 5, 2026PTCT PTC Therapeutics, IncSold$401K
Mar 3, 2026CRNX Crinetics Pharmaceuticals, IncSold$119K
Jan 2, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Jan 2, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Nov 20, 2025PTCT PTC Therapeutics, IncSold (not open market)—

Companies traded

  • CRNX Crinetics Pharmaceuticals, Inc: 4 sales, last Sep 1, 2026
  • PTCT PTC Therapeutics, Inc: 7 sales, last Mar 10, 2026
  • CTLT Catalent, Inc: other filings, last Dec 18, 2024
  • ALBO Albireo Pharma, Inc: other filings, last Mar 2, 2023

Get free alerts when Stephanie Okey files a new trade →